Onyx BiotecNSE:ONYX +2.08%13 Gross Margin % is 26.81% as of Mar. 2026, which is 27% below its 10-year median of 36.84. GuruFocus rates NSE:ONYX with a GF Score™ of 13/100. The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Onyx Biotec ranks worse than 85.96% on this metric.
The historical rank and industry rank for Onyx Biotec's Gross Margin % or its related term are showing as below:
NSE:ONYX'
s Gross Margin % Range Over the Past 10 Years
Min: 25.65 Med: 36.84 Max: 46.76
Current: 25.65
During the past 5 years, the highestGross Margin % of Onyx Biotec was 46.76%. The lowest was 25.65%. And the median was 36.84%.
NSE:ONYX's Gross Margin % is ranked worse than 85.96% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs NSE:ONYX: 25.65
Onyx Biotec had a gross margin of 26.81% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Onyx Biotec was 0.00% per year.
Onyx Biotec (NSE:ONYX) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Onyx Biotec had a gross margin of 26.81% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Onyx Biotec Gross Margin % Related Terms
Onyx Biotec Gross Margin % Historical Data
* Premium members only.
The historical data trend for Onyx Biotec's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ONYX vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Onyx Biotec's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Biotec Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Onyx Biotec's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Onyx Biotec's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Onyx Biotec (NSE:ONYX) has a Gross Margin % of 26.81% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Onyx Biotec and its competitors. This is 27% below median its historical median of 36.84. Over the past decade, Onyx Biotec's Gross Margin % has ranged from 25.65 to 46.76. According to the industry distribution chart, Onyx Biotec ranks #692 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 86%.
Is Onyx Biotec's Gross Margin % too high?
Onyx Biotec's current Gross Margin % of 26.81% is 27% below median its 10-year median of 36.84. Over the past 10 years, this metric has ranged from a low of 25.65 to a high of 46.76. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Onyx Biotec's value of 26.81% is 48.5% below this industry median. Based on the distribution chart, Onyx Biotec ranks #692 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Onyx Biotec has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Onyx Biotec ranks #692 out of 805 companies for Gross Margin %. This places Onyx Biotec in the lower half of its industry. The industry median Gross Margin % is 52.07. Onyx Biotec's value of 26.81% is 48.5% below this benchmark. Historically, Onyx Biotec's own Gross Margin % has ranged from 25.65 to 46.76 over the past decade. While the company's 10-year median is 36.84 vs. the industry median of 52.07, Onyx Biotec has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Biotec's current Gross Margin % of 26.81% is 48.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Onyx Biotec and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Biotec's current Gross Margin % is 26.81%, which is 27% below median its own 10-year median of 36.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current Gross Margin % of 26.81%. The current Gross Margin % is 26.81%, which is 27% below median its 10-year median of 36.84 and 48.5% below the Medical Devices & Instruments industry median of 52.07. Onyx Biotec's overall GF Score™ is 13/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current Gross Margin % is 26.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
13GF Score
Get the complete analysis for NSE:ONYX
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ONYX has been successfully added to your 